Tumores neuroendocrinos: impacto de LANREÓTIDA en la supervivencia de la enfermedad estable y progresiva - page 6

ANTIPROLIFERATIVE EFFECT OF SSA

IN PATIENTS WITHOUT DOCUMENTED PD

Toumpanakis C, et al.

Semin Oncol

2013

OR ~5%

SD 60-70%

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5 7,8,9,10,11,12,13,14,15,16,...26